Vasculitis in children

Brogan, 2000, Vasculitis from the pediatric perspective, Curr Rheumatol Rep, 2, 411, 10.1007/s11926-000-0041-7 Ozen, 2006, EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides, Ann Rheum Dis, 65, 936, 10.1136/ard.2005.046300 Saulsbury, 2007, Clinical update: Henoch-Schonlein purpura, Lancet, 369, 976, 10.1016/S0140-6736(07)60474-7 Gedalia, 2004, Henoch-Schonlein purpura, Curr Rheumatol Rep, 6, 195, 10.1007/s11926-004-0068-2 Gardner-Medwin, 2002, Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins, Lancet, 360, 1197, 10.1016/S0140-6736(02)11279-7 Yang, 2008, The immunobiology of Henoch-Schonlein purpura, Autoimmun Rev, 7, 179, 10.1016/j.autrev.2007.11.012 Lau, 2007, Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura, Pediatr Nephrol, 22, 2067, 10.1007/s00467-007-0623-y Brogan, 2007, What's new in the aetiopathogenesis of vasculitis?, Pediatr Nephrol, 22, 1083, 10.1007/s00467-007-0450-1 Peru, 2008, Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year period, Clin Rheumatol, 10.1007/s10067-008-0868-2 Chang, 2004, Gastrointestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients, Acta Paediatr, 93, 1427, 10.1111/j.1651-2227.2004.tb02623.x Ebert, 2008, Gastrointestinal Manifestations of Henoch-Schonlein Purpura, Dig Dis Sci, 10.1007/s10620-007-0147-0 Chang, 2005, Renal manifestations in Henoch-Schonlein purpura: a 10-year clinical study, Pediatr Nephrol, 20, 1269, 10.1007/s00467-005-1903-z Narchi, 2005, Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review, Arch Dis Child, 90, 916, 10.1136/adc.2005.074641 Hamdan, 2008, Henoch-Schonlein purpura in children. Influence of age on the incidence of nephritis and arthritis, Saudi Med J, 29, 549 de Almeida, 2007, Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of initial prognostic factors, J Pediatr (Rio J), 83, 259 Roberts, 2007, Henoch-Schonlein purpura: a review article, South Med J, 100, 821, 10.1097/SMJ.0b013e3180f62d0f Weiss, 2007, Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review, Pediatrics, 120, 1079, 10.1542/peds.2007-0667 Huber, 2004, A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura, BMC Med, 2, 7, 10.1186/1741-7015-2-7 Ronkainen, 2006, Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial, J Pediatr, 149, 241, 10.1016/j.jpeds.2006.03.024 Dillon, 2007, Henoch-Schonlein purpura: recent advances, Clin Exp Rheumatol, 25, S66 Zaffanello, 2007, Therapy for children with henoch-schonlein purpura nephritis: a systematic review, Scientific WorldJournal, 7, 20, 10.1100/tsw.2007.23 Wright, 2007, Childhood vasculitis and plasma exchange, Eur J Pediatr, 166, 145, 10.1007/s00431-006-0212-2 Ronkainen, 2002, The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study, Lancet, 360, 666, 10.1016/S0140-6736(02)09835-5 Rees, 2007 Newburger, 2004, Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, Pediatrics, 114, 1708, 10.1542/peds.2004-2182 Pinna, 2008, Kawasaki disease: an overview, Curr Opin Infect Dis, 21, 263, 10.1097/QCO.0b013e3282fbf9cd Park, 2007, Kawasaki disease in Korea, 2003–2005, Pediatr Infect Dis J, 26, 821, 10.1097/INF.0b013e318124aa1a Newburger, 2004, Kawasaki disease, Curr Opin Pediatr, 16, 508, 10.1097/01.mop.0000137796.23813.64 Burns, 2007, The riddle of Kawasaki disease, N Engl J Med, 356, 659, 10.1056/NEJMp068268 Amano, 1980, General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations, Acta Pathol Jpn, 30, 681 Newburger, 2003, Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4–7, 2001, Hakone, Japan, Pediatr Res, 53, 153 Bronstein, 2000, Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998, Pediatr Infect Dis J, 19, 1087, 10.1097/00006454-200011000-00012 Rowley, 2005, Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease, J Infect Dis, 192, 1757, 10.1086/497171 Chang, 2006, Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan, J Infect Dis, 193, 283, 10.1086/498875 Matsubara, 2006, Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease, Clin Exp Immunol, 143, 427, 10.1111/j.1365-2249.2006.03015.x Onouchi, 2008, ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms, Nat Genet, 40, 35, 10.1038/ng.2007.59 Burns, 2004, Kawasaki syndrome, Lancet, 364, 533, 10.1016/S0140-6736(04)16814-1 Brogan, 2002, Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research, Arch Dis Child, 86, 286, 10.1136/adc.86.4.286 Durongpisitkul, 1995, The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment, Pediatrics, 96, 1057 Terai, 1997, Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose, J Pediatr, 131, 888, 10.1016/S0022-3476(97)70038-6 Han, 2000, Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease, Arch Pediatr Adolesc Med, 154, 694, 10.1001/archpedi.154.7.694 Udi, 2008, Intravenous immunoglobulin - Indications and mechanisms in cardiovascular diseases, Autoimmun Rev, 7, 445, 10.1016/j.autrev.2008.04.001 Inoue, 2006, A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome, J Pediatr, 149, 336, 10.1016/j.jpeds.2006.05.025 Newburger, 2007, Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease, N Engl J Med, 356, 663, 10.1056/NEJMoa061235 Burns, 2005, Infliximab treatment for refractory Kawasaki syndrome, J Pediatr, 146, 662, 10.1016/j.jpeds.2004.12.022 Newburger, 2007, Kawasaki Disease, Curr Treat Options Cardiovasc Med, 9, 148, 10.1007/s11936-007-0008-3 Ozen, 2004, Juvenile polyarteritis: results of a multicenter survey of 110 children, J Pediatr, 145, 517, 10.1016/j.jpeds.2004.06.046 Rogalski, 2007, Panarteritis cutanea benigna–an entity limited to the skin or cutaneous presentation of a systemic necrotizing vasculitis? Report of seven cases and review of the literature, Int J Dermatol, 46, 817, 10.1111/j.1365-4632.2007.02975.x Pagnoux, 2006, Vasculitides secondary to infections, Clin Exp Rheumatol, 24, S71 Cordier, 2008, Pulmonary manifestations of the vasculitides, Rev Prat, 58, 492 David, 1993, Polyarteritis nodosa associated with streptococcus, Arch Dis Child, 69, 685, 10.1136/adc.69.6.685 Trepo, 1974, The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa, J Clin Pathol, 27, 863, 10.1136/jcp.27.11.863 Bakkaloglu, 2001, The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa, Arch Dis Child, 85, 427, 10.1136/adc.85.5.427 Brogan, 2003, T cell Vbeta repertoires in childhood vasculitides, Clin Exp Immunol, 131, 517, 10.1046/j.1365-2249.2003.02081.x Ozen, 2001, Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF?, Semin Arthritis Rheum, 30, 281, 10.1053/sarh.2001.19958 Schmidt, 2004, Use of imaging studies in the diagnosis of vasculitis, Curr Rheumatol Rep, 6, 203, 10.1007/s11926-004-0069-1 Brogan, 2002, Renal angiography in children with polyarteritis nodosa, Pediatr Nephrol, 17, 277, 10.1007/s00467-002-0823-4 Dillon, 2006, Vasculitis treatment - new therapeutic approaches, Eur J Pediatr, 165, 351, 10.1007/s00431-005-0070-3 Jayne, 2003, A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies, N Engl J Med, 349, 36, 10.1056/NEJMoa020286 de Kort, 2006, Infliximab in a child with therapy-resistant systemic vasculitis, Clin Rheumatol, 25, 769, 10.1007/s10067-005-0071-7 Sonomoto, 2008, Nihon Rinsho Meneki Gakkai Kaishi, 31, 119, 10.2177/jsci.31.119 Melo M, Pilkington C, Hasson N, et al. Biologics in vasculitis of the young. Abstract. Young Investigators Meeting, 2006. Callen, 2006, Livedoid vasculopathy: what it is and how the patient should be evaluated and treated, Arch Dermatol, 142, 1481, 10.1001/archderm.142.11.1481 Brogan PA, Shah V, Dillon MJ. Polyarteritis nodosa in childhood. Abstract. 10th International Vasculitis and ANCA workshop. Cleveland, 2002. Cheung, 2002, Arterial distensibility in children and teenagers: normal evolution and the effect of childhood vasculitis, Arch Dis Child, 87, 348, 10.1136/adc.87.4.348 Zwerina, 2008, Churg-Strauss Syndrome in Childhood: A Systematic Literature Review and Clinical Comparison with Adult Patients, Semin Arthritis Rheum Belostotsky, 2002, Clinical features in 17 paediatric patients with Wegener granulomatosis, Pediatr Nephrol, 17, 754, 10.1007/s00467-002-0914-2 Akikusa, 2007, Clinical features and outcome of pediatric Wegener's granulomatosis, Arthritis Rheum, 57, 837, 10.1002/art.22774 Peco-Antic, 2006, Childhood microscopic polyangiitis associated with MPO-ANCA, Pediatr Nephrol, 21, 46, 10.1007/s00467-005-2063-x Lane, 2005, Epidemiology of systemic vasculitis, Curr Rheumatol Rep, 7, 270, 10.1007/s11926-005-0036-5 Park, 2005, Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification, Scand J Rheumatol, 34, 284, 10.1080/03009740510026526 Cakar, 2008, Takayasu arteritis in children, J Rheumatol, 35, 913 Desai, 2005, Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience, AJR Am J Roentgenol, 184, 1427, 10.2214/ajr.184.5.01841427 Webb, 2006, Molecular imaging of Takayasu's arteritis and other large-vessel vasculitis with 18F-FDG PET, Nucl Med Commun, 27, 547, 10.1097/00006231-200607000-00001 Liang, 2005, Advances in the medical and surgical treatment of Takayasu arteritis, Curr Opin Rheumatol, 17, 16, 10.1097/01.bor.0000146607.65808.37 Ozen, 2007, Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate, J Pediatr, 150, 72, 10.1016/j.jpeds.2006.10.059 Hoffman, 2004, Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis, Arthritis Rheum, 50, 2296, 10.1002/art.20300 Liang, 2004, Takayasu's arteritis: vascular interventions and outcomes, J Rheumatol, 31, 102